Stay updated on Pembrolizumab with Post-op Radiotherapy in CSCC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab with Post-op Radiotherapy in CSCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab with Post-op Radiotherapy in CSCC Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    Updated the page’s displayed application/release version indicator from v3.5.2 to v3.5.3.
    Difference
    0.1%
    Check dated 2026-04-24T05:40:45.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    Site revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:12:52.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    Revision: v3.5.0 implemented, replacing v3.4.3. No study content changes are visible.
    Difference
    0.1%
    Check dated 2026-03-19T05:15:55.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.4.3, replacing v3.4.2. This appears to be a minor version update without changes to study content or user-facing features.
    Difference
    0.1%
    Check dated 2026-03-11T23:37:16.000Z thumbnail image
  7. Check
    82 days ago
    Change Detected
    Summary
    Removal of metadata topics 'Head and neck squamous cell carcinoma' and related terms like 'MedlinePlus Genetics' from the page may affect indexing and search filters, but does not change the trial content or eligibility details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-02-18T16:26:35.000Z thumbnail image
  8. Check
    89 days ago
    Change Detected
    Summary
    Adds contextual tags such as 'Head and neck squamous cell carcinoma' and related topic links (MedlinePlus Genetics) and updates revision notes; removes a government funding notice. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.6%
    Check dated 2026-02-11T11:30:06.000Z thumbnail image

Stay in the know with updates to Pembrolizumab with Post-op Radiotherapy in CSCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with Post-op Radiotherapy in CSCC Clinical Trial page.